UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.141

Sortiert nach

Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution

Drug resistance updates, 2019-05, Vol.44, p.100640-100640, Article 100640

2019

Link zum Volltext

Verfügbarkeit prüfen

The increasing threat of Pseudomonas aeruginosa high-risk clones

Drug resistance updates, 2015-07, Vol.21, p.41-59

2015

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients

Advanced drug delivery reviews, 2015-05, Vol.85, p.7-23

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections

Cell, 2018-01, Vol.172 (1-2), p.121-134.e14

2018

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response

Journal of molecular biology, 2015-11, Vol.427 (23), p.3628-3645

2015

Link zum Volltext

Verfügbarkeit prüfen

Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia

The Journal of infection, 2014-09, Vol.69 (3), p.216-225

2014

Link zum Volltext

Verfügbarkeit prüfen

Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm

International journal of antimicrobial agents, 2018-08, Vol.52 (2), p.172-179

2018

Link zum Volltext

Verfügbarkeit prüfen

The social life of microbes in chronic infection

Current opinion in microbiology, 2020-02, Vol.53, p.44-50

2020

Link zum Volltext

Verfügbarkeit prüfen

Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance

The Journal of infection, 2017-02, Vol.74 (2), p.142-152

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria

International journal of antimicrobial agents, 2014-01, Vol.43 (1), p.52-59

2014

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic-free nanotherapeutics: Ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors

Journal of controlled release, 2014-10, Vol.192, p.131-140

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Type Three Secretion System in Pseudomonas aeruginosa

Trends in pharmacological sciences (Regular ed.), 2016-09, Vol.37 (9), p.734-749

2016

Link zum Volltext

Verfügbarkeit prüfen

Current Knowledge and Future Directions in Developing Strategies to Combat Pseudomonas aeruginosa Infection

Journal of molecular biology, 2020-09, Vol.432 (20), p.5509-5528

Dolan, Stephen K.

2020

Link zum Volltext

Verfügbarkeit prüfen

Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides

Peptides (New York, N.Y. : 1980), 2014-12, Vol.62, p.32-37

2014

Link zum Volltext

Verfügbarkeit prüfen

1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A

European journal of medicinal chemistry, 2021-01, Vol.209, p.112892-112892, Article 112892

2021

Link zum Volltext

Verfügbarkeit prüfen

An innovative role for luteolin as a natural quorum sensing inhibitor in Pseudomonas aeruginosa

Life Sciences, 2021-06, Vol.274, p.119325-119325, Article 119325

2021

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways

Trends in microbiology (Regular ed.), 2009-03, Vol.17 (3), p.130-138

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia

International journal of antimicrobial agents, 2021-12, Vol.58 (6), p.106450-106450, Article 106450

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis

International journal of antimicrobial agents, 2018-01, Vol.51 (1), p.1-9

2018

Link zum Volltext

Verfügbarkeit prüfen

Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa

International journal of antimicrobial agents, 2024-05, Vol.63 (5), p.107119-107119, Article 107119

2024

Link zum Volltext

Verfügbarkeit prüfen

Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany

International journal of antimicrobial agents, 2020-06, Vol.55 (6), p.105959-105959, Article 105959

2020

Link zum Volltext

Verfügbarkeit prüfen

Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance

Respiratory medicine, 2015-06, Vol.109 (6), p.716-726

2015

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin

Current opinion in microbiology, 2021-12, Vol.64, p.125-132

2021

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

International journal of pharmaceutics, 2016-02, Vol.498 (1-2), p.263-273

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.141

Suche als RSS-Feed

Aktive Filter

SpracheTürkisch

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.109)
Mit Volltextzugriff
(1.124)

Publikationsform

Artikel
(1.141)

Sprache

Englisch
(1.127)
Japanisch
(108)
Französisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.012)
Life Sciences & Biomedicine
(987)
Humans
(972)
Pseudomonas Infections - Drug Therapy
(708)
Pseudomonas Aeruginosa
(511)
Pseudomonas Aeruginosa - Drug Effects
(453)
Male
(431)
Anti-Bacterial Agents - Therapeutic Use
(401)
Female
(391)
Infectious Diseases
(387)
Biological And Medical Sciences
(343)
Medical Sciences
(321)
Microbial Sensitivity Tests
(302)
Pharmacology & Pharmacy
(296)
Anti-Bacterial Agents - Pharmacology
(289)
Microbiology
(288)
Adult
(264)
Middle Aged
(254)
Pseudomonas Infections - Microbiology
(252)
Animals
(224)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution

The increasing threat of Pseudomonas aeruginosa high-risk clones

Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients

Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections

Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response

Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia

Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm

The social life of microbes in chronic infection

Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance

Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria

Antibiotic-free nanotherapeutics: Ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors

Targeting the Type Three Secretion System in Pseudomonas aeruginosa

Current Knowledge and Future Directions in Developing Strategies to Combat Pseudomonas aeruginosa Infection

Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides

1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A

An innovative role for luteolin as a natural quorum sensing inhibitor in Pseudomonas aeruginosa

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways

Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia

Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis

Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa

Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany

Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance

Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin

Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

Aktive Filter

Suchergebnisse filtern